A reduced proteomic signature in critically ill covid-19 patients determined with plasma antibody micro-array and machine learning

HIGHLIGHTS

• What: This study has identified a reduced protein signature for COVID-19 patients that contributes to COVID-19 pathophysiology characterization and may inform the development of therapeutic interventions upon further investigation. The authors identified a novel 28-protein signature and an optimal 9-protein signature that accurately classifies COVID-19 patients from non-COVID-19 sepsis controls and healthy control subjects; however, the study has several limitations.
• Who: Douglas D. Fraser and collaborators from the (UNIVERSITY) have published the Article: RESEARCH Open Access, in the Journal: (JOURNAL)
• How: A pairwise comparison using cosine . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.